US Patent Issued to GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT on June 9 for "Processes for the production of oligonucleotides" (British Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,939, issued on June 9, was assigned to GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT Ltd. (Stevenage, Great Britain).

"Processes for the production of oligonucleotides" was invented by Andreas Crameri (Stevenage, Great Britain) and David Graham Tew (Stevenage, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to novel processes using enzymes for the production of oligonucleotides, wherein said processes are suitable for use in the production of chemically modified oligonucleotides, such as those for use in therapy."

The patent was filed on Dec. 17, 2018, under Application No. 16/771,362.

*For further information...